Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![FactPoint Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::2485800751.png) Fact Point [@FactPoint](/creator/twitter/FactPoint) on x 396.7K followers
Created: 2025-07-19 09:31:07 UTC

Japanese scientists, led by Dr. Hideyuki Okano at Keio University, have gained regulatory approval for a human trial using induced pluripotent stem cells, which are adult cells reprogrammed to behave like embryonic stem cells. This marks a significant step forward in regenerative medicine.

![](https://pbs.twimg.com/media/GwNeNm7WsAAuE0p.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946503055932801412/c:line.svg)

**Related Topics**
[marks](/topic/marks)
[regulatory](/topic/regulatory)
[$9008t](/topic/$9008t)

[Post Link](https://x.com/FactPoint/status/1946503055932801412)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

FactPoint Avatar Fact Point @FactPoint on x 396.7K followers Created: 2025-07-19 09:31:07 UTC

Japanese scientists, led by Dr. Hideyuki Okano at Keio University, have gained regulatory approval for a human trial using induced pluripotent stem cells, which are adult cells reprogrammed to behave like embryonic stem cells. This marks a significant step forward in regenerative medicine.

XXX engagements

Engagements Line Chart

Related Topics marks regulatory $9008t

Post Link

post/tweet::1946503055932801412
/post/tweet::1946503055932801412